Skip to main content

Table 3 Baseline characteristics of anti-HCV NAT positive and NAT negative transplant recipients

From: Hepatitis C positive organ transplantation to negative recipients at a multiorgan Canadian transplant centre: ready for prime time

Recipient characteristics

Anti-HCV NAT positive organs (N = 22)

Anti-HCV NAT negative organs (N = 11)

Age (years)

47.5 (42.3–62.0)

56 (47–65.0)

Male gender (%)

13 (59.1)

6 (54.5)

Etiology of transplant

A. Kidney (%)

 Diabetes

4 (18.2)

1 (9.1)

 Hypertension

1 (4.5)

4 (36.4)

 PCKD

3 (13.6)

1 (9.1)

 Nephrotic syndrome

1 (4.5)

1 (9.1)

 GN

2 (9.1)

0 (0)

 IgA nephropathy

2 (9.1)

0 (0)

 Light chain deposition disease

1 (4.5)

0 (0)

 Vasculitis

0 (0)

2 (18.2)

 Alport syndrome

1 (4.5)

0 (0)

 Reflux nephropathy

1 (4.5)

0 (0)

 ATN

1 (4.5)

0 (0)

 NYD

1 (4.5)

0 (0)

B. Liver (%)

 ASH

1 (4.5)

2 (18.2)

 HCV

1 (4.5)

0 (0)

 Hepatocellular carcinoma

2 (9.1)

0 (0)

C. Heart (%)

 Ischemic cardiomyopathy

1 (4.5)

0 (0)

CMV (D+/R−) (%)

Mismatch

4 (18.2)

3 (27.3)

  1. Data are number of patients (%) or median (IQR)
  2. GN glomerulonephritis, PCKD polycystic kidney disease, IgA immunoglobulin A, ATN acute tubular necrosis, NYD,not yet determined, ASH alcoholic steatohepatitis, CMV cytomegalovirus, D donor, R,recipient
  3. *Both recipients were treated for HCV (SVR 12 achieved) and were HCV NAT negative before transplant